ACNS1831
OPEN TO ACCRUAL
Phase 3 Rand Selumetinib vs. Carbo/Vinc in Newly Dx or Previously Untreated NF1 LGG
ACNS1931
OPEN TO ACCRUAL
Phase 3 study of Selumetinib vs Selumetinib/Vinblastine for non-NF1 recurrent/progressive LGG
ACNS2021
OPEN TO ACCRUAL
Phase 2 Chemo followed by WVSC Irradiation for patients with NGGCT
ACNS2031
OPEN TO ACCRUAL
Phase 3 Sodium Thiosulfate used in Medulloblastoma to Reduce Hearing Loss for Children
ACNS2321
OPEN TO ACCRUAL
Ph 2 Trial of Chemo followed by Response-Based Reduced XRT in Pts w/ CNS Germinomas